celecoxib has been researched along with Dehiscence, Surgical Wound in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Up to 30% of cancer patients undergoing curative surgery develop local recurrences due to positive margins." | 1.38 | A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation. ( Aliperti, LA; Cheng, G; Fridlender, ZG; Judy, B; Kapoor, V; Madajewski, B; Okusanya, O; Predina, JD; Quatromoni, J; Singhal, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Predina, JD | 1 |
| Judy, B | 1 |
| Fridlender, ZG | 1 |
| Aliperti, LA | 1 |
| Madajewski, B | 1 |
| Kapoor, V | 1 |
| Cheng, G | 1 |
| Quatromoni, J | 1 |
| Okusanya, O | 1 |
| Singhal, S | 1 |
1 other study available for celecoxib and Dehiscence, Surgical Wound
| Article | Year |
|---|---|
A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Chemotherapy, A | 2012 |